Amerisource, one of the country’s largest pharmaceutical distributors, said it would pay about $6 billion for Walgreens’ wholesaling division, Reuters reported.
Walgreens and AmerisourceBergen have been in talks in the past about potential deals, including one in 2018 for Walgreens to purchase AmerisourceBergen.
Walgreens owns about 26 percent of Amerisource and is Amerisource’s largest customer.
Walgreens said in early April that the COVID-19 pandemic has caused its sales to drop by a mid-teens percentage as there is less foot traffic in stores and fewer sales of things like beauty products.
A spokesperson for AmerisourceBergen told Becker’s Hospital Review the company has no comment on the matter.
Becker’s has also reached out to Walgreens for comment and will update this story accordingly.
More articles on pharmacy:
6 federal pharmacy policy changes in response to the COVID-19 pandemic
Clinical trials for COVID-19 drugs & when to expect results
Walgreens lowers prices on hundreds of prescription drugs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.